Modeling and therapeutic targeting of inflammation-induced hepatic insulin resistance using human iPSC-derived hepatocytes and macrophages
Abstract Hepatic insulin resistance is recognized as a driver of type 2 diabetes and fatty liver disease but specific therapies are lacking. Here we explore the potential of human induced pluripotent stem cells (iPSCs) for modeling hepatic insulin resistance in vitro, with a focus on resolving the c...
Main Authors: | Marko Groeger, Koji Matsuo, Emad Heidary Arash, Ashley Pereira, Dounia Le Guillou, Cindy Pino, Kayque A. Telles-Silva, Jacquelyn J. Maher, Edward C. Hsiao, Holger Willenbring |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-07-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-39311-w |
Similar Items
-
iPSC-derived cells for whole liver bioengineering
by: Kayque Alves Telles-Silva, et al.
Published: (2024-02-01) -
Adipocyte inflammation is the primary driver of hepatic insulin resistance in a human iPSC-based microphysiological system
by: Lin Qi, et al.
Published: (2024-09-01) -
An Efficient Method for the Differentiation of Human iPSC-Derived Endoderm toward Enterocytes and Hepatocytes
by: Shimeng Qiu, et al.
Published: (2021-04-01) -
Forskolin induces FXR expression and enhances maturation of iPSC-derived hepatocyte-like cells
by: Christiane Loerch, et al.
Published: (2024-04-01) -
Improvements in Maturity and Stability of 3D iPSC-Derived Hepatocyte-like Cell Cultures
by: Siiri Suominen, et al.
Published: (2023-09-01)